Kanglin Biotechnology has raised $20 million in financing to advance the development of sickle cell gene therapy KL003.
Research indicates that a carbohydrate-reduced, high-protein diet improves lipid metabolism and reduces liver fat in type 2 ...
In a report released on December 3, Julian Harrison from BTIG maintained a Buy rating on Keros Therapeutics (KROS – Research Report), with a ...